Gwendal Le Masson

Université de Bordeaux — France

Medicine · Health Sciences

33h-index5.6kcitations146works7.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peripheral Neuropathies and Disorders(35), Neural dynamics and brain function(28), Neuroscience and Neural Engineering(24), Amyotrophic Lateral Sclerosis Research(23), Hereditary Neurological Disorders(22)

Publications144 total

Prevalence of <scp><i>SOD1</i></scp> and <scp><i>C9orf72</i></scp> Variants Among French <scp>ALS</scp> Population: The <scp>GENIALS</scp> Study
European Journal of Neurology·2025· 5 citedOpen Access
When neuromuscular disorders become stars
Journal of Neurology·2025
Efficacy and safety of efgartigimod PH20 subcutaneously (sc) in chronic inflammatory demyelinating polyneuropathy (CIDP): results from the ADHERE/ADHERE+ studies
Nervenheilkunde·2025
Pan-neurofascin autoimmune nodoparanodopathy: A case report and literature review
Medicine·2025· 2 citedOpen Access
The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis
International Journal of Molecular Sciences·2024· 3 citedOpen Access
Efficacy and Safety of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyneuropathy: Results of ADHERE/ADHERE+
Neurology·2024Open Access
Changes in Non-invasive Ventilation Compliance in Patients With Amyotrophic Lateral Sclerosis: A Post-hoc Analysis
Archivos de Bronconeumología·2024· 1 cited
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
The Lancet Neurology·2024· 67 citedOpen Access
Factors associated with survival after early at-home NIV initiation in ALS patients
Journal of Neurology·2024· 2 cited
The various forms of hereditary motor neuron disorders and their historical descriptions
Journal of Neurology·2024· 4 cited
Analyse des préoccupations des patients vivant avec la sclérose latérale amyotrophique et de leurs aidants, à partir de leurs témoignages sur les forums publics de l’internet français
Revue Neurologique·2024
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
Trials·2023· 12 citedOpen Access
Clinical Neurology in Practice
The Neurologist·2023· 5 cited
Clinical Neurology in Practice
The Neurologist·2023· 3 cited
At-home noninvasive ventilation initiation with telemonitoring in amyotrophic lateral sclerosis patients: a retrospective study
ERJ Open Research·2022· 21 citedOpen Access
À propos de 12 cas d’intoxication au protoxyde d’azote diagnostiqués au CHU de Bordeaux en 2021 : nécessité du dosage de l’homocystéine totale plasmatique, biomarqueur de la carence cellulaire en vitamine B12
Therapies·2022
LE POISSON-ZÈBRE : UNE AIDE RAPIDE À L’INTERPRÉTATION DES VARIANTS RARES DANS LA SLA
SPIRE - Sciences Po Institutional REpository·2022
Acute peripheral neuropathy following animal envenomation: A case report and systematic review
Journal of the Neurological Sciences·2022· 6 cited
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study
Journal of Neurology·2022· 4 citedOpen Access
The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
Neurology and Therapy·2022· 8 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Stéphane Mathis(10), Claude Desnuelle(5), Guilhem Solé(5), Antoine Soulages(4), Jean‐Michel Vallat(4), Sylvie Renaud(4), Pascal Cintas(4), Philippe Corcia(4), André Garenne(4), Jean Tomas(4), Philippe Couratier(4), Shahram Attarian(3), Émilien Delmont(3), Cyril Goizet(3), Damien Debay(3), Thierry Bal(3), Nathalie Guy(3), Jean‐Philippe Camdessanché(3), Fanny Farrugia(3), Daniel Gonzalez‐Dunia(3)